Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
Doug Brown, partner with Manatt Health and current chair of the AHA’s Foster G. McGaw Prize Committee, discusses how hospitals are tackling food insecurity,…
Headline
Obesity rates for U.S. children and teenagers have reached record highs, while rates for adults had a slight decline, according to reports by the Centers for…
Headline
A new AHA blog shares examples of hospitals and health systems working together with Area Agencies on Aging to address the social needs of older adults and…
Blog
One-fifth of Americans age 50 or older live alone, increasing their risk of social isolation and loneliness — factors associated with serious health problems…
Headline
Life expectancy in the U.S. reached an all-time high of 79 years in 2024, according to a report by the Centers for Disease Control and Prevention. The average…
Headline
Ji Im, system senior director of community and population health at CommonSpirit Health, explores why seamless navigation, community partnerships and…